The use of the antiarrythmic drug amiodarone (AD) has been limited by the propensity of the
drug to cause severe lung damage. AD has been shown to produce a transient pulmonary …

Amiodarone is a potent antidysrhythmic agent that can cause potentially life-threatening
pulmonary fibrosis. Accumulating evidence has demonstrated that myofibroblast …

Background: Amiodarone (AD) is a strong anti-arrhythmic drug but has adverse reactions on
different organs. Fish oil which is rich in Omega-3 polyunsaturated fatty acids (omega-3 …

Amiodarone, a common and effective antiarrhythmic drug, has been reported to have anti-
inflammatory effects such as reducing the activation and movement of neutrophils. However …

Amiodarone (AD) has been shown to produce a transient pulmonary fibrosis in hamsters
after intratracheal (it) instillation. The goal of this study was to examine bronchoalveolar …

Background: Chronic interstitial pneumonitis is the most common presentation of
amiodarone-induced pulmonary disease. Aim of the work: To throw a light on the damage of …

Administration of amiodarone, although often lifesaving, is associated with pulmonary side
effects. Patients with amiodarone pulmonary toxicity can present with either a chronic …

Amiodarone (AM) is a potent antidysrhythmic agent that is limited in clinical use by its
adverse effects, including potentially life-threatening AM-induced pulmonary toxicity (AIPT) …

Amiodarone (AM) is an effective antidysrhythmic agent, restricted in use by the development
of adverse effects, including potentially fatal AM‐induced pulmonary toxicity (AIPT). Although …

Amiodarone (AM) is a potent antidysrhythmic agent that can cause potentially life-
threatening pulmonary fibrosis, and N-desethylamiodarone (DEA), an AM metabolite, may …